Fingolimod Reduces Annual Brain Volume Loss in MSFingolimod Reduces Annual Brain Volume Loss in MS

Results of 2 trials show that fingolimod decreases the annual rate of brain volume loss in patients with MS. Setting thresholds compared with healthy adults may help to define disease-free activity. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news